MENU

Eureka projects

Development of CMTM6 inhibitors: Modulation of PDL1 for cancer treatment
Cut-off: 
8
Ranking: 
74
Project ID: 
11889

Biofabrication of 3D soft tissue models with a tissue-printing technology and a biosynthetic nanocellulose Cellink.

From Continuous Glucose Monitoring to Cont Glucose Microneedle Monitoring for efficient open & closed-loop diabetes treatment

Reactive Oxygen Species (ROS) Activators to Treat the Rare disease Guillain-Barré Syndrome (GBS)

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.